Item(by='altrus', descendants=None, kids=None, score=None, time=1603199436, title=None, item_type='comment', url=None, parent=24836764, text='Additional commentary and background can be found in Science;<p><a href="https:&#x2F;&#x2F;www.sciencemag.org&#x2F;news&#x2F;2020&#x2F;10&#x2F;could-certain-covid-19-vaccines-leave-people-more-vulnerable-aids-virus" rel="nofollow">https:&#x2F;&#x2F;www.sciencemag.org&#x2F;news&#x2F;2020&#x2F;10&#x2F;could-certain-covid-...</a><p>The concerns raised in this article do not speak to the efficacy of candidate vaccines using Ad5 vectors. Rather, they discuss the potential impact Antibody-dependent enhancement might have on at risk groups, and, as a consequence, for the design of clinical trials using those vectors.')